These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15254920)

  • 1. Delirium in elderly hospitalised patients: protective effects of chronic rivastigmine usage.
    Dautzenberg PL; Mulder LJ; Olde Rikkert MG; Wouters CJ; Loonen AJ
    Int J Geriatr Psychiatry; 2004 Jul; 19(7):641-4. PubMed ID: 15254920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine].
    Kalisvaart CJ; Boelaarts L; de Jonghe JF; Hovinga IM; Kat MG
    Ned Tijdschr Geneeskd; 2004 Jul; 148(30):1501-4. PubMed ID: 15481575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rivastigmine in prevention of delirium in a 65 years old man with Parkinson's disease.
    Dautzenberg PL; Wouters CJ; Oudejans I; Samson MM
    Int J Geriatr Psychiatry; 2003 Jun; 18(6):555-6. PubMed ID: 12789683
    [No Abstract]   [Full Text] [Related]  

  • 4. Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.
    Bullock R; Touchon J; Bergman H; Gambina G; He Y; Rapatz G; Nagel J; Lane R
    Curr Med Res Opin; 2005 Aug; 21(8):1317-27. PubMed ID: 16083542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis.
    Dybicz SB; Keohane DJ; Erwin WG; McRae T; Shah SN
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):154-60. PubMed ID: 16860262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Co-morbidity in acutely hospitalised older patients as a risk factor for death in hospital or within 3 months after discharge].
    de Rooij SE; Buurman BM; korevaar JC; Van Munster BC; Schuurmans MJ; Laqaaij AM; Verhaar HJ; Levi M
    Ned Tijdschr Geneeskd; 2007 Sep; 151(36):1987-93. PubMed ID: 17953173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer's disease: a placebo-controlled pilot study.
    Mahlberg R; Walther S; Eichmann U; Tracik F; Kunz D
    Arch Gerontol Geriatr; 2007; 45(1):19-26. PubMed ID: 16963137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine].
    van den Bliek BM; Maas HA
    Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2149; author reply 2149. PubMed ID: 15553363
    [No Abstract]   [Full Text] [Related]  

  • 9. Adding rivastigmine to antipsychotics in the treatment of a chronic delirium.
    Dautzenberg PL; Mulder LJ; Olde Rikkert MG; Wouters CJ; Loonen AJ
    Age Ageing; 2004 Sep; 33(5):516-7. PubMed ID: 15315924
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
    Mol JA
    Ned Tijdschr Geneeskd; 2003 Apr; 147(14):679; author reply 679. PubMed ID: 12712655
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical characteristics and risk factors of delirium in demented and not demented elderly medical inpatients.
    Margiotta A; Bianchetti A; Ranieri P; Trabucchi M
    J Nutr Health Aging; 2006; 10(6):535-9. PubMed ID: 17183425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment effects of rivastigmine on cognition, performance of daily living activities and behaviour in Alzheimer's disease in an outpatient geriatric setting.
    Frankfort SV; Appels BA; De Boer A; Tulner LR; Van Campen JP; Koks CH; Beijnen JH
    Int J Clin Pract; 2006 Jun; 60(6):646-54. PubMed ID: 16805746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ethical aspects of anti-Alzheimer drugs: experiences of caregivers].
    Huizing AR; Berghmans RL; Widdershoven GA; Verhey FR
    Tijdschr Gerontol Geriatr; 2002 Dec; 33(6):246-51. PubMed ID: 12611287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does home treatment affect delirium? A randomised controlled trial of rehabilitation of elderly and care at home or usual treatment (The REACH-OUT trial).
    Caplan GA; Coconis J; Board N; Sayers A; Woods J
    Age Ageing; 2006 Jan; 35(1):53-60. PubMed ID: 16239239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting.
    Aguglia E; Onor ML; Saina M; Maso E
    Curr Med Res Opin; 2004 Nov; 20(11):1747-52. PubMed ID: 15537474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of nonanticholinergic delirium with a cholinesterase inhibitor.
    Fischer P
    J Clin Psychopharmacol; 2001 Feb; 21(1):118. PubMed ID: 11199939
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease.
    Burn D; Emre M; McKeith I; De Deyn PP; Aarsland D; Hsu C; Lane R
    Mov Disord; 2006 Nov; 21(11):1899-907. PubMed ID: 16960863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a German version of the Confusion Assessment Method for delirium detection in a sample of acute geriatric patients with a high prevalence of dementia.
    Hestermann U; Backenstrass M; Gekle I; Hack M; Mundt C; Oster P; Thomas C
    Psychopathology; 2009; 42(4):270-6. PubMed ID: 19521144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rivastigmine in the treatment of alcohol-induced persisting dementia.
    Gibson RC; Barnaby L
    West Indian Med J; 2003 Mar; 52(1):59-61. PubMed ID: 12806761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years.
    Farlow MR; Lilly ML;
    BMC Geriatr; 2005 Jan; 5():3. PubMed ID: 15659242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.